Phil Noland Roberts - Dec 13, 2023 Form 4 Insider Report for Immunome Inc. (IMNM)

Role
Chief Technology Officer
Signature
/s/ Sandra Stoneman, Attorney-in-fact
Stock symbol
IMNM
Transactions as of
Dec 13, 2023
Transactions value $
$0
Form type
4
Date filed
12/15/2023, 07:28 PM
Previous filing
Dec 15, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMNM Stock option (right to buy) Award $0 +275K $0.00 275K Dec 13, 2023 Common Stock 275K $7.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the options vest on December 8, 2024, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter.